Classification
Product TypeProcessed Food
Product FormDietary supplement (tablets, gummies, effervescent)
Industry PositionConsumer Health / Nutraceutical Product
Market
Vitamin C supplements in Pakistan are marketed as non-prescription health/OTC products and fall under DRAP’s Alternative Medicines and Health Products scope, which explicitly includes vitamins and minerals. Market supply is supported by both domestic nutraceutical brands and multinational brands, with products commonly sold through pharmacies/medical stores and online channels. Imports are structurally important for finished supplements and/or raw materials, and market access is strongly shaped by DRAP enlistment/authorization and port-clearance controls designed to prevent entry of unapproved or suspected falsified goods. Product positioning in Pakistan is strongly skewed toward immunity support and convenient dose forms such as standard tablets and effervescent dissolvable tablets.
Market RoleImport-dependent consumer market with domestic nutraceutical manufacturing/marketing presence
Domestic RoleNon-prescription consumer health category (Health & OTC) sold via pharmacy and e-commerce channels
Risks
Regulatory Compliance HighNoncompliance with DRAP’s Health & OTC / Alternative Medicines framework (e.g., lack of appropriate enlistment/authorization, missing required port-clearance documentation, or nonconforming labeling/claims) can result in refusal of entry, clearance delays, or market withdrawal for vitamin C supplement consignments.Engage an eligible local importer/market authorization holder early; confirm product route (Health & OTC vs drug registration), align labeling/claims to DRAP requirements, and pre-audit the DRAP document set (forms, CoA, batch certificate, invoice/packing list, remaining shelf life) before shipment.
Product Authenticity HighPakistan’s therapeutic goods supply chain faces ongoing enforcement actions against falsified/spurious products; vitamin and supplement products sold through informal or unverified channels can create elevated authenticity and consumer-safety risk.Source only through authorized channels; implement batch-level traceability, tamper-evident packaging, and distributor audits; monitor DRAP recall/rapid alert notices and align procurement to verified suppliers.
Quality Assurance MediumDocumentation or test-method gaps (e.g., missing/insufficient Certificate of Analysis or recognized monograph reference where required) can trigger holds at clearance and raise downstream buyer rejection risk.Maintain a complete QA dossier per DRAP import/export guidance (CoA, batch certification, recognized test references where applicable) and perform pre-shipment conformity checks against importer and DRAP expectations.
Trade Finance MediumForeign-exchange liquidity constraints and LC processing frictions have been reported to disrupt pharmaceutical/API import flows in Pakistan, which can also affect supplement supply continuity where imports are required.Diversify payment terms and suppliers; plan longer lead times; coordinate with banking partners early and maintain safety stock buffers for fast-moving SKUs.
Labor & Social- Counterfeit/spurious therapeutic goods risk: market integrity and consumer safety can be undermined by falsified or spurious products circulating through informal or non-authorized channels, increasing reputational and liability exposure for legitimate supply chains.
Standards- cGMP (Current Good Manufacturing Practice) expectations as part of establishment oversight for Health & OTC manufacturers/importers
FAQ
Are vitamin C supplements regulated by DRAP in Pakistan?Yes. DRAP’s Alternative Medicines and Health Products scope explicitly includes vitamin and mineral products, and DRAP states these products are regulated under the DRAP Act 2012 and the Alternative Medicines and Health Products (Enlistment) Rules, 2014.
What documents are commonly needed to import vitamin C supplements (Health & OTC) into Pakistan?DRAP’s import/export guidance lists documentation commonly used for Health & OTC consignments, including the relevant DRAP arrival/intimation forms, company/product enlistment copies (where applicable), a batch certificate, a Certificate of Analysis, commercial invoice, packing list, Bill of Lading/Air Waybill, evidence of remaining shelf life, and proof of fee payment (challan) where applicable.
What is the most common compliance risk for vitamin C supplements entering Pakistan?The biggest risk is regulatory noncompliance (missing authorization/enlistment, incomplete documentation, or nonconforming labeling/claims), which DRAP notes can lead to refusal of entry or clearance problems because DRAP applies import controls to prevent noncompliant or suspected falsified therapeutic goods from entering the supply chain.